Literature DB >> 34006916

Non-dipping pattern of nocturnal blood pressure as a risk factor for macular ischemia in branch retinal vein occlusion.

Gwang Myeong Noh1, Haeyoung Lee2, Hyun Duck Kwak3, Hyun Wong Kim3, Sang Joon Lee4.   

Abstract

Branch retinal vein occlusion (BRVO) is ocular vascular disease affecting approximately 14 million people worldwide, and is closely associated with high blood pressure (BP). Although macular ischemia is a critical factor in the visual prognosis of BRVO, the relationship between macular ischemia and different patterns of nocturnal BP is unknown. Here, we investigated whether a dipping pattern of nocturnal BP is associated with the development of macular ischemia in patients with BRVO. A total of 273 patients were reviewed; of these, 86 (86 eyes) patients were included. All recruited patients had a macular thickness map by optical coherence tomography and underwent 24-h ambulatory BP monitoring. According to their dipping patterns, the participants were divided into dipper and non-dipper groups. The non-dipper group had worse visual outcomes at the initial and 6-month visits (P = 0.014 and P = 0.003, respectively). Five of 32 eyes (15.6%) in the dipper group and 32 of 54 (59.3%) in the non-dipper group had macular ischemia. In a multivariate analysis, the night-to-day systolic BP ratio was associated with the degree of macular ischemia (β = - 0.313, P = 0.004). Thus, a non-dipping pattern may be a risk factor for macular ischemia in patients with BRVO.

Entities:  

Year:  2021        PMID: 34006916     DOI: 10.1038/s41598-021-89915-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  2 in total

1.  Nocturnal blood pressure epidemiology, determinants, and effects of antihypertensive therapy.

Authors: 
Journal:  Blood Press Monit       Date:  1998-02       Impact factor: 1.444

2.  24-hour ambulatory blood pressure and renal disease in young subjects with type I diabetes.

Authors:  S K Garg; H P Chase; G Icaza; R L Rothman; I Osberg; J A Carmain
Journal:  J Diabetes Complications       Date:  1997 Sep-Oct       Impact factor: 2.852

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.